Regents of the University of California’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Regents of the University of California’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-62,023	Closed	-$2.68M	–	35
2020 Q4	$2.68M	Hold	62,023	–	–	0.39%	10
2020 Q3	$2.55M	Sell	62,023 -23,097	-27%	-$1.19M	0.35%	8
2020 Q2	$5.11M	Buy	+85,120	New	+$7.8M	0.72%	7

Other funds holding ORTX

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Regents of the University of California's ORTX Position: Q1 2021 in Review

Regents of the University of California sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2021, closing a stake of 62,023 shares — an estimated $2.68M sold.

Regents of the University of California first reported a position in ORTX in Q2 2020 and held it in 3 quarters. The position peaked at $5.11M in Q2 2020. 83 funds tracked by Wall St. Rank hold ORTX as of Q1 2021.

Regents of the University of California reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2021 after selling out during the quarter.
Regents of the University of California sold 62,023 Orchard Therapeutics plc American Depositary Shares shares in Q1 2021, an estimated $2.68M.
Regents of the University of California first reported a position in Orchard Therapeutics plc American Depositary Shares in Q2 2020 and held it in 3 quarters.
Regents of the University of California's Orchard Therapeutics plc American Depositary Shares position peaked at $5.11M in Q2 2020.
83 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2021.

Based on Regents of the University of California's 13F filing for Q1 2021, filed 20 Apr 2021.